Vision Extrusions Group LTD is a recognized leader in the building products industry. They produce a wide range of products (as shown in Figure 1) including windows, doors, decks, fences, etc. utilizing extruded polymeric profiles as a substitute for wood. In the proposed project, the following objectives have been set by the partner organization to […]

Epilepsy is a debilitating neurological disorder affecting approximately 50 million people worldwide (World Health Organization). This project proposes to develop a SMART (Seizure Monitoring At the Right Time) Headset for these patients to monitor their brain signal and track their movements, heart rates and breathing patterns. This headset will have new types of sensors suitable […]

This project proposes a scalable quantum-enhanced generative model for drug discovery, targeting the design of KRAS inhibitors through the integration of Neural Quantum States (NQS), Quantum Circuit Born Machines (QCBMs), and CUDA Quantum acceleration. By replacing traditional quantum circuits with adaptive NQS representations and extending QCBM capacity to 32 qubits, the framework enables more expressive […]

Apical periodontitis is a disease caused by the persistence of microorganisms and their virulence factors in the root canal system. This infection leads to inflammation of the soft tissues and changes in the periapical bone structure. Bacteria such as Fusobacterium nucleatum and Parvimonas micra form biofilms that are resistant to conventional cleaning, making treatment more […]

Many people with heart failure are not prescribed the full set of guideline-directed medical therapies (GDMT), which can shorten their lifespan and reduce quality of life. One major reason is the difficulty and inconvenience of regularly checking potassium and creatinine levels, which are needed to safely adjust these medications. To address this, we are developing […]

This project will support the commercialization of a new medical training tool designed to help doctors learn how to perform technically complex procedures for cancer staging and diagnosis. The partner organization, University Health Network, has developed a realistic 3D-printed simulation model that enables trainees to safely practice this procedure outside the operating room. Unlike current […]

Our academic lab has developed technology that could have potential benefits in the Canadian healthcare system. This technology is highly specialized that combines MRI and interventional cardiac treatment. The intern will determine if our technology can satisfy the needs dictated by various stakeholders in the industry, such that a startup is warranted. This objective will […]

The mission of PI16 Therapeutics is to improve skin health for the ~4 million Canadian’s suffering from long-term skin diseases, including clinically dry skin, chronic wounds, and severe burns. PI16 Therapeutics aims to produce skin solutions for these individuals by genetically engineering naturally occurring stem-cell like fibroblasts that express the gene Peptidase Inhibitor 16 (Pi16) […]

The challenge to be addressed in this project is to develop a next generation of machine-learning-guided data validation and annotation tools that take account of differences in human judgment and decision-making processes.

This project will focus on helping to bring the DialySnake, which is a novel medical device, closer to market. The DialySnake is a low-cost, minimally invasive tool designed to unclog blocked peritoneal dialysis (PD) catheters at patients’ bedsides in an average of 5 minutes. Currently, when peritoneal dialysis catheters become blocked, hospitals often rely on […]

The GeneSight (GS) Psychotropic Test (AssureRx Health, Inc.) measures individual variations in drug-related genes and recommends optimal drug choices for individual patients. A clinical study will be conducted to validate novel gene markers of antipsychotic-induced weight gain for use in an enhanced version of GS. Sarah Groleau will be responsible for genotyping DNA from 600 […]

The GeneSight (GS) Psychotropic Test (AssureRx Health, Inc.) measures individual variations in drug-related genes and recommends optimal drug choices for individual patients. A clinical study will be conducted to validate novel gene markers of antipsychotic-induced weight gain for use in an enhanced version of GS. Sarah Groleau will be responsible for genotyping DNA from 600 […]